- Home
- BUSE vs BHVN Comparison
BUSE vs BHVN Comparison
Compare BUSE & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUSE
- BHVN
- Stock Information
- Founded
- BUSE 1868
- BHVN 2013
- Country
- BUSE United States
- BHVN United States
- Employees
- BUSE N/A
- BHVN N/A
- Industry
- BUSE Major Banks
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- BUSE Finance
- BHVN Health Care
- Exchange
- BUSE Nasdaq
- BHVN Nasdaq
- Market Cap
- BUSE 1.9B
- BHVN 1.9B
- IPO Year
- BUSE N/A
- BHVN 2017
- Fundamental
- Price
- BUSE $22.73
- BHVN $16.88
- Analyst Decision
- BUSE Buy
- BHVN Strong Buy
- Analyst Count
- BUSE 5
- BHVN 14
- Target Price
- BUSE $27.80
- BHVN $59.85
- AVG Volume (30 Days)
- BUSE 470.9K
- BHVN 2.3M
- Earning Date
- BUSE 07-22-2025
- BHVN 05-12-2025
- Dividend Yield
- BUSE 4.42%
- BHVN N/A
- EPS Growth
- BUSE N/A
- BHVN N/A
- EPS
- BUSE 0.95
- BHVN N/A
- Revenue
- BUSE $430,476,000.00
- BHVN N/A
- Revenue This Year
- BUSE $63.55
- BHVN N/A
- Revenue Next Year
- BUSE $12.78
- BHVN $59.97
- P/E Ratio
- BUSE $23.69
- BHVN N/A
- Revenue Growth
- BUSE 0.48
- BHVN N/A
- 52 Week Low
- BUSE $18.40
- BHVN $14.33
- 52 Week High
- BUSE $28.97
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- BUSE 59.35
- BHVN 46.71
- Support Level
- BUSE $22.05
- BHVN $15.48
- Resistance Level
- BUSE $22.86
- BHVN $15.94
- Average True Range (ATR)
- BUSE 0.46
- BHVN 0.94
- MACD
- BUSE 0.00
- BHVN 0.34
- Stochastic Oscillator
- BUSE 91.03
- BHVN 93.18
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech and Wealth Management. The banking segment generates a vast majority of its revenue.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.